Spectulation
Aldosterone is known to control sodium and potassium excretion by kidneys, sweat glands, and salivary glands. In patients with classic pseudohypoaldosteronism there is a defect in renal tubular response to aldosterone action. Studies in the present patient suggest that there may be variants of this syndrome in which the end organ defect is in the sweat and salivary glands instead of the renal tubule. In addition, it is possible that new variants will be found in which end organ defect is in still other organs concerned with electrolyte transport.
Pseudohypoaldosteronism is an uncommon renal tubular disorder characterized by urinary sodium wasting and is manifested by repeated episodes of dehydration, hyponatremia, and hyperkalemia ( I , 5, 7, l I, 17, 22, 32-35, 37, 38.44) . The abnormality in this condition is attributed to an end organ defect in the distal renal tubule with failure of response to endogenous aldosterone. Aldosterone secretion and/or urinary excretion rates are usually elevated (I I, 22, 33, 34) , but during very high sodium intake in some patients the rates fall to the normal range (1 1, 22). Other adrenocortical functions are normal. Sweat sodium and/or chloride determinations, when measured, have been reported to be normal (5. l I, 34. 35) .
We have observed a 3.5-year-old Caucasian girl with normal growth and development who, during the first 19 months of her life, developed repeated episodes of hyponatremia, hyperkalemia, and dehydration with serum sodium as low as 113 mEq/liter and serum potassium as high as 1 1 . 1 mEq/liter. Her plasma aldosterone level and urinary aldosterone excretion rates were persistently elevated whereas other adrenocortical functions were normal. Unlike other patients with classic pseudohypoaldosteronism, she had no urinary sodium wasting when studied during dietary sodium restriction and her sweat and salivary sodium concentrations were persistently elevated. She did not appear to have cystic fibrosis. This report describes studies related to changes in sodium intake and their effects on sodium balance and aldosterone production. The results suggest that this child represents a new variant of pseudohypoaldosteronism in which the end organ defect is in the sodium metabolism of sweat and salivary glands instead of the renal tubule.
CASE REPORT R C is a 43-month-old Caucasian girl who was first referred to the Riley Children's Hospital (Indiana University Medical Center) at 28 days of age for failure to thrive, difficulty in breathing, and shock. She was the product of a normal pregnancy and delivery of a 28-year-old mother. Birth weight was 3.6 kg. At 2 days of age she began to vomit after each meal. Multiple formula changes resulted in no improvement. At 21 days of age she was admitted to another hospital because of persistent vomiting and weight loss. The patient's failure to thrive was thought to be secondary to poor feeding, and management consisted of another change in brand of formula, after which her vomiting improved and she started to gain weight. One day before transfer to the Riley Hospital, however. her condition worsened and she developed pallor and respiratory distress. The patient is the only child of her parents but has five half-siblings. There is no family history of adrenogenital syndrome. recurrent pulmonary ~nfections, or cystic fibrosis.
Physical examination revealed a moderately dehydrated girl in shock and with unobtainable blood pressure. Heart rate was 160/min with irregular rhythm, respiratory rate was 35/1nin, and temperature 37'. Weight was 3.0 kg. The remainder of her physical examination, including external genitalia, was normal. Initial laboratory data revealed a hemoglobin of 13.8 g/100 ml with normal white blood count and differential. Urinalysis was normal. Serum sodium concentration was 119 mEq. potassium 11.1 mEq, chloride 76 mEq, and carbon dioxide content 22 mmol/liter. The serum urea nitrogen was 71 mg, glucose 79 mg, calcium 9.5 mg, and phosphorus 6.1 mg/100 ml. Roentgenograms of the chest and abdomen were normal. Electrocardiogram revealed tall T waves and occasional ventricular premature beats. The differential diagnosis included congenital adrenal hyperplasia with salt loss, congenital Addison's disease, congenital aldosterone systhesis defect, pseudohypoaldosteronism. or some renal abnormality.
The patient was managed with intravenous fluids, hydrocortisone, and deoxycorticosterone acetate (DOCA). When her condition stabilized, her glucocorticoid function was evaluated while on DOCA and dexamethasone. The baseline values for 17-keto and 17-OH steroids and pregnanetriol were 0.65 mg, 4.3 mg/m2. and 0.02 mg, respectively; the normal values for children of similar age on no medication are < 2 mg, 3 I mg/m" and <O.2 mg, respec-
tively. In response to intramuscular ACTH stimulation, 17-OH steroids increased 23-fold on days 1 and 2 and 9-fold on day3, thus excluding the possibility of congenital Addison's disease. Renal function studies, summarized in Table 1 , were normal. During the first 4 weeks of her first admission (age 4-8 weeks), despite treatment with hydrocortisone and DOCA or 9-n-fluorocortisol and 5-8 mEq/kg/day sodium intake, her serum potassium concentration was more than 6 mEq/liter on 10 different days and more than 8 mEq/liter on 3 different days. On these 3 days the serum sodium concentration was also less than 130 mEq/liter.
SPECIAL STUDIES
These studies were done during four periods between the ages of 2 months and 35 months. Each study period lasted 1-3 weeks. If sodium intake during this period was changed, at least 3 days o f equilibration were permitted before any determinations were made. Sodium and potassium intake in the diet were calculated, and any sodium supplements to the diet were measured. The patient was allowed free access to water and was ambulatory after the first year of life. All blood samples for plasma aldosterone and renin activity measurements were collected in the morning, after at least 4 hr of continuous supine position.
METHODS
Serum, urinary, sweat, and salivary sodium and potassium concentrations were measured by flame photometry with lithium as the internal standard. Sweat chloride concentration was measured by chloridometer. Sweat was collected by pilocarpine iontophoresis, and the rate of sweat production was calculated as described by Lobeck and Huebner (24) . Saliva for sodium and potassium determination was collected from the sublingual region. Stool fat determination was made by standard methods. Serum Table 1 . Rena1,function studies (age 4-8 weeks) and urinary pancreatic amylase were measured by polyacrylamide gel electrophoresis (28) . Urinary aldosterone determinations were done by the method of Kliman and Peterson (19) . Plasma aldosterone was measured by radioimmunoassay during s f u d~j period 2 using paper chromatography (27) and in srudy periods 3 a n d 4 using an antibody capture method (13) . Plasma renin activity was measured by radioirnmunoassay for angiotensin 1 (16) . Red blood cell sodium and potassium concentrations were measured as described by Zarkowski er al. (45) .
RESULTS

STUDY PERIOD I: EFFECTS OF VARYING SODIUM INTAKE (FIG. I )
This study was done at age 8-12 weeks and was initiated 2 days after the patient's serum sodium and potassium had been restored to normal by increased sodium intake. Throughout this period, 2-4 mg DOCA/day was administered intramuscularly. During the first 10 days of study she was also given hydrocortisone, 5 mg/day.
During the first 10 days of the study the patient had 12-24 mEq sodium intake/day (4-8 mEq/kg/day). Despite this intake, from day 3 onward the serum sodium was consistently less than 135 mEq/liter. Serum potassium was higher than 5.5 mEq/liter throughout these 10 days. Her urinary aldosterone excretion at this time was elevated to 43 ~g / 2 4 hr (normal value for children on a d libitum sodium intake is 2-26 ~g / 2 4 hr). On the I Ith day she developed diarrhea and dehydration. Her weight decreased by 4%, serum sodium decreased to 121 mEq/liter, and serum potassium increased to 8.3 mEq/liter. The patient was given an increased amount of sodium and fluid over the next 4 days to correct dehydration and hyponatremia.
From day 16 through 24 ( Fig. I , right half) she was given a high sodium intake of 40-60 mEq/day ( I 2 1 6 mEq/kg/day). With this level of sodium intake she gained weight and the serum sodium and potassium were normal on most days.
INTERVAL I
Blood urea nitrogen (when well hydrated) 5-8 mg/ 100 ml The patient was discharged on a daily sodium supplement of Serum creatinine 0.5 mg/ I00 ml 30-40 mEq to her diet. During the next 10 months she grew Creatinine clearance [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] 
temia. Her mother also described that at home the patient sweated excessively. (FIG. 2) This study was done at age 12 months. From day 1 through 7 , despite a daily sodium intake of 40-50 mEq (5-6 mEq/kg/day), normal serum sodium concentration, and no weight gain, urinary excretion of sodium was only 3-10 mEq/day. Stool sodium at this time was less than 1 mEq/day. A sweat chloride concentration, obtained to help account for the 35-40 mEq difference between daily sodium intake and output, was elevated to 116 mEq/liter (normal less than 30) on dull 3 and I36 mEq/liter on day 7. The peripheral venous plasma renin activity (PRA) collected on day 3 was 16 ng/ml/3 hr (normal value for supine P R A in adults on ad libitum sodium intake in our laboratory I; 1 .O-3.0 ng/ml/3 hr and during high sodium intake less than 1.5 ng/ml/3 hr; although results in normal young children have not been adequately standardized in our laboratory, in three normal children between the ages of 5 months and 2 years, supine P R A while on normal diet was less than 22 ng/ml/3 hr in all. Stalker et 01. (42) have recently reported that plasma renin activity in infants between the ages of 2 months and 3 years is 4.6 i 0.9 ng/ml/hr). Her plasma aldosterone was elevated to more than 73 ng/100 ml (47) (in two normal infants while on normal diet results of supine plasma aldosterone in our laboratory were 17-28 ng/ 100 ml, respectively, and in two children with cystic fibrosis, aged 6 months and 4 years, results were 29 and 8 ng/100 ml, respectively. Kowarski er al. (20) , using a different technique, have recently reported that mean plasma aldosterone in infants less than 1 year of age was 79.9 i 47.9 ng/100 ml and in children 1-15 years of age 24.9 * 17.6 ng/ 100 ml). The patient's potassium intake during this study period varied between 20 and 30 mEq/day and urinary potassium excretion between 5 and 15 mEq/day even though through most of this period her serum potassium was higher than 5.5 mEq/liter. Un- der usual circumstances when hyperkalemia is present, the urinary excretion of potassium rises and limits a further rise in serum potassium concentrations.
STUDY PERIOD 2: SODIUM BALANCE STUDY
From day 15 through 22 ( Fig. 2, right half) the patient's daily sodium intake was reduced to 18-24 mEq (2-3 mEq/kg/day). Her weight and serum sodium concentration gradually fell and serum potassium concentration remained above normal throughout this period. On day 21 (while her serum sodium concentration and weight were decreasing) her P R A was markedly increased over the value on day 3. Plasma aldosterone on day 21 (10) . On day 22 she developed further weight loss and her serum urea nitrogen rose to 50 mg/ 100 ml. Her condition was stabilized over the next 3 days by administration of additional sodium. One week after this she was placed on 9-cu-fluorocortisol, 0.1 mg daily for 6 days, after which sweat sodium was repeated and found to be 184 mEq/liter. Further evaluation for cystic fibrosis at this time, including a chest roentgenogram and 72-hr fecal fat excretion, was normal.
INTERVAL 2
During the next 22 months the patient was maintained on 35-70 mEq/day sodium supplement to her diet. Her blood pressure on this regimen was normal. During this period she developed only one recognized episode of hyponatremia. hyperkalemia, and azotemia at age 19 months. At age 26 months she developed a right middle lobe pneumonia; the infiltrate, however, took 12 months t o clear. Tuberculin test with intermediate strength purified bovine derivative (PPD) was negative. Her growth and development during this interval were normal.
STUDY PERIOD 3: EFFECTS OF GRADUAL REDUCTION OF SODIUM INTAKE (FIG. 3)
This study was done at age 33 months. Her sodium intake was reduced in a stepwise fashion from 100 mEq/kg/day (8 mEq/kg/ day) to 20 rnEq/kg/day (1.6 rnEq/kg/day). The urinary sodium excretion gradually fell so that when her daily sodium intake was 20 mEq, urinary sodium excretion was only 3 mEq. Her sweat sodium was still markedly elevated, but despite a 5-fold reduction in sodium intake her serum sodium and potassium concentrations increased to very high va~uks. Blood pressure was normal throughout the study period. Creatinine clearance during this admission was 139 ml/min/1.73 rn2, Red blood cell sodium concentration was 18 mEq/liter cells (normal, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] and potassium concentration 1 12 mEq/liter cells (normal. 82-108).
Fecal fat excretion was 7 8 of intake. Serum and urinary pancreatic amylase (amy-2) levels were normal. Patients with cystic fibrosis have little detectable pancreatic amylase (amy-2) in their serum or urine (28) . T o determine whether she sweated excessively her sweat production rate was determined: it was 8 g/mY/min. This is in the normal range both for normal children and children with cystic fibrosis (24) .
INTERVAL 3
After the above study she was discharged on a normal diet with no sodium supplement. O n the above regimen she continued to do well and to gain weight and maintain normal serum electrolytes. (FIG. 4) This study was done at age 35 months while on a regular diet with sodium intake varying between 20 and 35 mEq/day (2-3 ANAND ET A L mEq/kg/day). After baseline plasma aldosterone, PRA, and cortisol measurements, dexamethasone, I mg twice daily, was given orally for 4 days. The baseline cortisol level was normal and decreased markedly after dexamethasone. The baseline plasma aldosterone level was considerably elevated. One day after dexamethasone administration plasma aldosterone level showed further elevation; by the 4th day the level had fallen below baseline value but was still considerably above normal.
STUDY PERIOD 4: EFFECTS OF DEXAMETHASONE
SUBSEQUENT COURSE
Since the last study, the patient has been followed for 8 months on a regular diet. Her height and weight gain has been normal. Blood pressure has been 90-100 systolic and 60-70 diastolic. She has no evidence of pulmonary or gastrointestinal disease. She has maintained normal serum electrolytes. Sweat electrolytes were sodium 160 mEq/liter, chloride 139 mEq/liter, and potassium 7.7 mEq/liter.
DISCUSSION
Pseudohypoaldosteronism is an uncommon renal tubular disorder first described by Cheek and Perry in 1958 (5). Since then 19 additional patients have been reported ( I , 7, l I, 17, 22, 32-35, 37, 44) . During infancy all the reported patients had renal sodium wasting and urinary sodium concentration generally exceeded 30 mEq/liter even in the presence of hyponatremia unless the patients were extremely dehydrated. Aldosterone secretion or excretion rates were always high in these patients when they were on normal sodium intake. With very high sodium intakes in some reported patients these rates fell into the normal range (I 1, 22). whereas in most they continued to be extremely high (33, 34, 44) . When measured, sweat sodium or chloride concentrations have been less than 50 mEq/liter (5, l I, 34, 35) , except for one of the reported patients whose initial sweat sodium was 93 mEq/liter; however, a repeat value was 47 mEq/liter (35) .
Sweat sodium and/or chloride concentrations are elevated in a number of conditions including cystic fibrosis, hypoaldosteronism, tic fibrosis are reported to have either normal or partial loss of pancreatic function (8, 40) . Patients with cystic fibrosis are known to develop shock and hyponatremia with heat prostration (18) and occasionally dehydration and hyponatremia even in cold weather (9) . However, during these episodes, their serum potassium concentration is either normal or low (9) , and development of hyperkalemia has not been reported. Aldosterone secretion rate in young patients with cystic fibrosis has been previously reported to be normal (29) : however, the values in teenagers with advanced disease may be elevated (41) . Plasma aldosterone levels measured by us in two young children with cystic fibrosis were normal, unlike the patient of this report. Because of the reasons mentioned above, if this patient is to be considered a patient suffering from cystic fibrosis, she is a very unusual patient with the disorder. Furthermore, it must be postulated that she has two unrelated disorders, cystic fibrosis and a defect in aldosterone metabolism.
The clinical course in our patient has been very similar to patients with classic pseudohypoaldosteronism. Most of these patients, with increasing age (usually by 1-2 years). lose their tendency for excessive sodium wasting and can be maintained on normal diets ( I , I I, 33, 34) . In this respect our patient resembles the other reported patients. She differs, however, from all other reported cases of pseudohypoaldosteronism in that the source of her excessive sodium loss has been from the sweat glands instead of 
